What if we could identify the triggers that cause degeneration and disease?
Developing effective drugs for complex chronic diseases presents the largest opportunity to impact human healthspan, yet research is hindered by gaps in our understanding of the underlying biological processes that lead to disease
More than 60% of people over 65 have two or more chronic diseases.
.png)
Over the course of a human life span, many triggers lead to chronic disease. These triggers are currently unknown and undetectable
Our Platform
Teal has developed a platform that offers a deep multi-omic mapping of human biology. Our focus is to accelerate the development of novel precision medicines by building a first-of-its-kind analytics infrastructure that digitizes our knowledge of the molecular changes that occur throughout aging.
We partner with life science organizations around the world to accelerate research breakthroughs that will lead to novel precision medicines.
.png)
Teal's proprietary platform leverages harmonized data and proprietary analytic pipelines to generate novel biological insights; we aim to be the informatics layer of all complex proteomics research.
Our initial focus has been to build a first-of-its-kind biological map of brain aging and disease to accelerate the development of novel precision therapies for neurodegenerative diseases
Our Research
Our proprietary, multi-omics-based platform is built on one of the largest databases of human proteomic data and uniquely unravels the complexities of aging and disease. Our capabilities enable us to deeply characterize diseases and conduct granular patient profiling. We collaborate with life science leaders around the world who leverage our foundational AI models to answer critical questions and accelerate the development of novel therapeutics.
Aging Research
Understanding drug and environmental impacts on aging biology through comprehensive analysis.
Clinical Trial Optimization
Enhanced patient selection and trial stratification for improved study design
Novel Target Discovery
Identification and validation of novel therapeutic targets and pathways.
Biomarker Development
Disease and prognostic biomarker validation and development to enable precision medicine.
MOA Validation
Indication expansion and molecule repurposing through mechanism of action validation studies.
Proteomic Research
Enhancement of proteomic research capabilities and validation of insights.
Our Team
.png)
In the News
Accelerating precision medicine through advanced proteomics analytics and aging research.